Novo Integrated Sciences, Inc. (NVOS)
Market Cap | 7.10M |
Revenue (ttm) | 22.58M |
Net Income (ttm) | -12.36M |
Shares Out | 59.64M |
EPS (ttm) | -0.45 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 4,467,353 |
Open | 0.121 |
Previous Close | 0.125 |
Day's Range | 0.117 - 0.122 |
52-Week Range | 0.101 - 3.320 |
Beta | -0.15 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Jan 31, 2023 |
About NVOS
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and base... [Read more]
Financial Performance
In 2021, NVOS's revenue was $9.31 million, an increase of 18.38% compared to the previous year's $7.86 million. Losses were -$4.46 million, -9.22% less than in 2020.
Financial StatementsNews

Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today reported that it received a notice on January 25, 2023 from the Listing Qualification...

Why Is Novo Integrated Sciences (NVOS) Stock Up 27% Today?
Novo Integrated Sciences (NASDAQ: NVOS) stock is taking off on Tuesday despite a lack of news concerning the healthcare company. Instead, investors have heavy trading to thank for the rise in price t...

5 Health Care Stocks That Are Diving - And May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Novo Integrated Sciences Provides Update on Certain Current Actions and Events
BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International LLC (“CCI”), a Novo wholly-owned subsidiary, today a...

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.
BELLEVUE, Wash.

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions
BELLEVUE, Wash.

Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering
BELLEVUE, Wash.

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread
BELLEVUE, Wash.

Embracing Technology and Innovation “Key” to Easing Healthcare Crisis
VAUGHAN, Ontario--(BUSINESS WIRE)---- $NVOS #HealthCanadaNPN--Embracing Technology and Innovation “Key” to Easing Healthcare Crisis. Greater Toronto Area Company Improving Healthcare Delivery and Trea...

Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a...

Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a...

Novo Integrated Sciences' Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond

Novo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP

Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results.

Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC and Appoints Dr. Joseph Chalil as Chief Medical Officer

Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Signs MOU with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America

Novo Integrated Sciences' PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology

Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness throu...

Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest

Novo Integrated Sciences' IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada

Novo Integrated Sciences' IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number by Health Canada Proven to be Safe and Effective.

Novo Integrated Sciences Reports First Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Reports First Quarter Financial Results

Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Announces Signing of a Master Facility License Agreement with LA Fitness in Canada

Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product